In addition to these COX-2-driven molecular events that facilitate BC progression and invasion [239], COX-2-overexpressing BC cells can also promote indoleamine 2,3-dioxygenase (IDO) expression in fibroblasts. The gene discussed is IDO1; the disease is breast cancer.